This post was originally published on this site
In addition, promising results from Merck & Co., Inc.’s (MRK) oral COVID-19 treatment have provided some support. Furthermore, according to a Factset report, more S&P 500 companies have issued positive EPS guidance for the third quarter. Given this backdrop, several low-priced stocks with strong growth potential could be solid bets now.
Wall Street analysts expect shares of Arcos Dorados Holdings Inc . (NYSE:ARCO), Adecoagro S.A. (AGRO), and Cidara Therapeutics, Inc. (CDTX), which are trading at less than $10 but have solid growth potential, to rally 50% or more in price in the near term.
